PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Lilly

Eli Lilly and CompanyLilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

Lilly RSS Channel

Filters
List of articles in category Lilly
Title Published Date
Lilly and Lycia Therapeutics enter into strategic collaboration to discover and develop novel lysosomal targeting chimera (LYTAC) degraders 25 August 2021
Lilly, Evidation Health and Apple study shows personal digital devices may help in the identification of mild cognitive impairment and mild Alzheimer's disease dementia 09 August 2019
New online tool helps patient advocates navigate medicines development and evaluation process 26 March 2014
Jentadueto® (linagliptin/metformin hydrochloride) tablets recommended for approval 30 May 2012
BYETTA® approved for use with basal insulin in Europe 26 March 2012
ALIMTA Receives Positive Opinion from CHMP 27 September 2011
Lilly CEO Says Biopharmaceuticals Should Be Included in Transatlantic Trade and Economic Discussions 12 July 2011
ALIMTA(R) Recommended by Special Health Authority in United Kingdom 08 April 2010
Diabetes Conversation Map(TM) Education Tools Celebrate One-Year Anniversary 22 October 2009
Lilly Unveils Blueprint for Speeding Innovative Medicines to Patients 15 September 2009
Prasugrel Receives Positive Opinion from the European Committee for Medicinal Products for Human Use 17 December 2008
  1. You are here:  
  2. Home
  3. Eli Lilly and Company

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2025 PharmaNews.eu. All Rights Reserved.